{
    "clinical_study": {
        "@rank": "43608", 
        "arm_group": {
            "arm_group_label": "Open Label", 
            "arm_group_type": "Experimental", 
            "description": "Neural bridge system implant and external stimulator"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this clinical study is to allow the investigation of the Neural Bridging\n      System for participants with tetraplegia to assess if the investigational device can\n      reanimate a paralyzed limb under voluntary control by the participant's thoughts."
        }, 
        "brief_title": "Reanimation in Tetraplegia", 
        "completion_date": {
            "#text": "November 2019", 
            "@type": "Anticipated"
        }, 
        "condition": "Spinal Cord Injury (Quadreplegia)", 
        "condition_browse": {
            "mesh_term": [
                "Quadriplegia", 
                "Spinal Cord Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "detailed_description": {
            "textblock": "This study plans to enroll participants who have been diagnosed with C4- C6 ASIA A spinal\n      cord injuries (motor and sensory complete neurologic injuries), who are more than 1 year\n      post injury, and who are neurologically stable."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Must be 21 years or older.\n\n          -  Must be tetraplegic (C4- C6 ASIA A).\n\n          -  12 months post injury and neurologically stable.\n\n          -  Participant is willing to comply with all follow-up evaluations at the specified\n             times.\n\n          -  Participant is able to provide informed consent prior to enrollment in the study.\n\n          -  The participant is fluent in English.\n\n          -  Participant must have a caregiver willing to participate in the study who will\n             provide care for the surgical site.\n\n        Exclusion Criteria:\n\n          -  No active wound healing or skin breakdown issues.\n\n          -  No history of poorly controlled autonomic dysreflexia.\n\n          -  Medical contraindications for general anesthesia, craniotomy, or surgery.\n\n          -  Diagnosis of acute myocardial infarction or cardiac arrest within previous 6 months.\n\n          -  Participants with any type of destruction and/or damage to the motor cortex region as\n             determined by MRI.\n\n          -  History of psychiatric disturbance or dementia\n\n          -  Other implantable devices such as heart/brain pacemakers\n\n          -  Participants who rely on ventilators\n\n          -  Co-morbid conditions that would interfere with study activities or response to\n             treatment.\n\n          -  History of a neurological ablation procedure.\n\n          -  Labeled contraindication for MRI.\n\n          -  History of hemorrhagic stroke.\n\n          -  History of HIV infection or ongoing chronic infection (such as tuberculosis).\n\n          -  Pregnant or of child-bearing potential and are not taking acceptable methods of\n             contraception.\n\n          -  Participation in another FDA device or medication trial that would interfere with the\n             current study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "89 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "5", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01997125", 
            "org_study_id": "Reanimation in Tetraplegia", 
            "secondary_id": "G130055"
        }, 
        "intervention": {
            "arm_group_label": "Open Label", 
            "description": "Implanted device", 
            "intervention_name": "Neural Bridging System", 
            "intervention_type": "Device", 
            "other_name": [
                "Blackrock Microsystems Neuroport", 
                "Neuromuscular Stimulator"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 22, 2013", 
        "location": {
            "contact": {
                "email": "Phuong.Nguyen2@osumc.edu", 
                "last_name": "Phuong Nguyen", 
                "phone": "614-366-6952"
            }, 
            "contact_backup": {
                "email": "Kimberly.Mahler@osumc.edu", 
                "last_name": "Kimberly Mahler", 
                "phone": "614-366-6639"
            }, 
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43210"
                }, 
                "name": "The Ohio State University Wexner Medical Center - Center for Neuromodulation"
            }, 
            "investigator": {
                "last_name": "Ali Rezai, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Reanimation in Tetraplegia", 
        "overall_contact": {
            "email": "Phuong.Nguyen2@osumc.edu", 
            "last_name": "Phuong Nguyen", 
            "phone": "614-366-6952"
        }, 
        "overall_official": {
            "affiliation": "Ohio State University", 
            "last_name": "Ali Rezai, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary outcome measure of this study is the achievement of voluntary movement of the upper extremity.", 
            "measure": "Voluntary Movement", 
            "safety_issue": "No", 
            "time_frame": "9 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01997125"
        }, 
        "responsible_party": {
            "investigator_affiliation": "The Ohio State University", 
            "investigator_full_name": "Ali Rezai, MD", 
            "investigator_title": "MD", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "source": "Ohio State University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Ali Rezai, MD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}